Correlation Between Value Line and Trillium Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Value Line and Trillium Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Value Line and Trillium Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Value Line and Trillium Therapeutics, you can compare the effects of market volatilities on Value Line and Trillium Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Value Line with a short position of Trillium Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Value Line and Trillium Therapeutics.

Diversification Opportunities for Value Line and Trillium Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Value and Trillium is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Value Line and Trillium Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trillium Therapeutics and Value Line is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Value Line are associated (or correlated) with Trillium Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trillium Therapeutics has no effect on the direction of Value Line i.e., Value Line and Trillium Therapeutics go up and down completely randomly.

Pair Corralation between Value Line and Trillium Therapeutics

If you would invest (100.00) in Trillium Therapeutics on January 19, 2024 and sell it today you would earn a total of  100.00  from holding Trillium Therapeutics or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Value Line  vs.  Trillium Therapeutics

 Performance 
       Timeline  
Value Line 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Value Line has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Trillium Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Trillium Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward indicators, Trillium Therapeutics is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Value Line and Trillium Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Value Line and Trillium Therapeutics

The main advantage of trading using opposite Value Line and Trillium Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Value Line position performs unexpectedly, Trillium Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trillium Therapeutics will offset losses from the drop in Trillium Therapeutics' long position.
The idea behind Value Line and Trillium Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope